Trial intelligence / Profile preview

The Effects of Nitric Oxide for Inhalation on Myocardial Infarction Size

NCT01398384Phase 2Completed

Sponsor
UZ Leuven
Start
Oct 2010
Primary completion
May 2014
Modality
DNA Intercalators/Alkylators, Inhalation Devices
Countries
3
01

Overview

A Phase 2 trial of nitric oxide in acute myocardial infarction (AMI), sponsored by UZ Leuven. Started Oct 2010; status: completed.

02

Drugs

nitric oxide
03

Conditions

acute myocardial infarction (AMI)

Beyond the preview

Go deeper on NCT01398384.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01398384.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call